Video Experimental Relacionado
Updated: Jul 18, 2026
08:33
A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
Las citoquinas proinflamatorias en el asma aguda.
P H Brown1, G K Crompton, A P Greening
1Respiratory Unit, Northern General Hospital, Edinburgh, UK.
Lancet (London, England)
|September 7, 1991
Resumen
Este estudio encontró que si bien la activación de los linfocitos T ocurre en el asma, el receptor de interleucina-2 soluble en plasma (sIL-2R) no es un indicador confiable de la actividad de la enfermedad o la respuesta al tratamiento en pacientes con asma.
Área de la Ciencia:
- Inmunología Inmunología.
- Medicina de las vías respiratorias.
- La bioquímica es la bioquímica.
Sus antecedentes:
- La inflamación de las vías respiratorias en el asma implica interacciones complejas de citoquinas entre las células inmunes.
- Comprender estas interacciones es crucial para manejar el asma de manera efectiva.
Objetivo del estudio:
- Para investigar las concentraciones de citoquinas en la sangre periférica en adultos con asma de gravedad variable.
- Evaluar la utilidad del receptor de interleucina-2 soluble (sIL-2R) como marcador de la actividad del asma y la respuesta al tratamiento.
Principales métodos:
- Se midieron las concentraciones plasmáticas de varias citoquinas, incluido el factor estimulante de colonias de macrófagos de granulocitos (GM-CSF) y el receptor de interleucina-2 soluble (sIL-2R).
- Los niveles de citoquinas comparados entre los grupos: asma aguda grave, asma leve, asma crónica y controles sanos.
- Los niveles de sIL-2R monitoreados secuencialmente en pacientes con asma severa sometidos a tratamiento con esteroides.
Principales resultados:
- Los niveles de factor estimulante de colonias de macrófagos de granulocitos (GM-CSF) fueron significativamente más altos en pacientes con asma grave en comparación con los controles sanos.
- Las concentraciones plasmáticas de sIL-2R fueron elevadas en todos los grupos de asma en comparación con los individuos sanos, pero no diferían entre los niveles de gravedad del asma.
- Si bien los niveles de sIL-2R disminuyeron significativamente después de 7 días de tratamiento con esteroides, este cambio no se correlacionó con la mejora clínica en el flujo expiratorio máximo.
Conclusiones:
- El estudio confirma la activación de los linfocitos T en el asma.
- El plasma sIL-2R no es un biomarcador sensible o confiable para monitorear la actividad de la enfermedad del asma o predecir la eficacia del tratamiento.
- Se necesita más investigación para identificar mejores biomarcadores para el manejo del asma.
Videos de Conceptos Relacionados
01:38Inflammation
Overview
01:30Inflammatory Response I: Vascular and Cellular
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:26Acute Inflammation I: Inflammatory Response
Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
01:26Acute Inflammation II: Cellular Phase
The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...